CAPPED BONUSZERTIFIKAT - MERCK & CO. Share Price

Certificat

DE000PC67M88

Market Closed - Börse Stuttgart 08:36:59 31/05/2024 BST
101.3 EUR -0.71% Intraday chart for CAPPED BONUSZERTIFIKAT - MERCK & CO.
Current month-1.57%
1 month-1.57%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
31/05/24 101.3 -0.71%
30/05/24 102 +0.43%
29/05/24 101.6 -0.25%
28/05/24 101.8 -0.46%
27/05/24 102.3 -0.48%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 08:36 am

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC67M8
ISINDE000PC67M88
Date issued 25/03/2024
Strike 120 $
Maturity 20/06/2025 (384 Days)
Parity 1 : 1
Emission price 98.2
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 103.1
Lowest since issue 100
Spread 0.02
Spread %0.02%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
125.5 USD
Average target price
141.9 USD
Spread / Average Target
+13.01%
Consensus